The India Cord Blood Banking Market was valued at USD 33.71 Million in 2024 and is expected to grow to USD 55.30 Million by 2033. The market exhibits a CAGR of 5.20% during the forecast period of 2025-2033. Growth is driven by increased awareness of stem cell therapies, a rise in genetic disorders, expanding healthcare infrastructure, government initiatives, disposable income, and advancements in cryopreservation technology. The report presents a thorough review featuring the India Cord Blood Banking Market Trends, share, trends, and research of the industry.

STUDY ASSUMPTION YEARS

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

INDIA CORD BLOOD BANKING MARKET KEY TAKEAWAYS

• Current Market Size: USD 33.71 Million in 2024

• CAGR: 5.20%

• Forecast Period: 2025-2033

• Rising awareness of stem cell therapies and genetic disorders significantly boost market demand.

• Expansion of healthcare infrastructure supports market growth.

• Increasing disposable incomes enable greater adoption of private cord blood banking.

• Advancements in cryopreservation technology enhance service effectiveness.

• Growing investments in private and public cord blood banking services drive expansion.

Sample Request Link: https://www.imarcgroup.com/india-cord-blood-banking-market/requestsample

MARKET TRENDS

The India cord blood banking industry is increasingly adopting private banking services as expectant parents become better informed about stem cell therapeutic possibilities. India’s young population, with a median age of 30 and 40% under 25 years, leads to approximately 24 million births annually. This demographic and growing middle class with rising incomes drive more families to privately store their newborns’ cord blood for potential future medical use.

Private cord blood banks offer individualized storage solutions where stem cells remain accessible only to the donor and their relatives. Aggressive marketing and flexible payment schemes have broadened access to private banking. However, the high costs of private banking restrict access for many, with ongoing debates on the comparative benefits of public versus private storage, contributing significantly to the market's growth.

Government and healthcare organizations in India are expanding public cord blood banking, recognizing its critical role in providing stem cell transplants for treating life-threatening diseases such as leukemia and thalassemia. Public banks operate by accepting donated cord blood for use by any suitable patient, enhancing genetic unit diversity. Despite challenges such as storage shortages and donor education gaps, increased funding and partnerships with hospitals stimulate donations and market growth.

MARKET GROWTH FACTORS

Growth in India’s cord blood banking market is driven by rising awareness of stem cell therapies and the increased prevalence of genetic and chronic diseases. Enhanced knowledge enables more families to consider cord blood preservation as a viable healthcare investment. Expansion of healthcare infrastructure and government backing further support market development.

Technological advancements in cryopreservation and stem cell storage improve practical applications and efficiency, making therapies more accessible and effective. Ongoing research in regenerative medicine benefits from improved storage technologies, fostering confidence in the market's long-term potential.

Increasing disposable incomes in India’s expanding middle class empower families to invest in private cord blood banking services. Aggressive marketing strategies combined with flexible payment options widen the market reach. Simultaneously, investments in public and private biobanking services support infrastructure improvements, lowering costs and improving accessibility.

Speak To an Analyst For a Customized Report

MARKET SEGMENTATION

Service Insights:

• Sample Preservation and Storage: Services focused on maintaining cord blood viability through effective storage techniques.

• Sample Analysis: Analytical services assessing the quality and viability of cord blood samples.

• Sample Processing: Procedures carried out to prepare cord blood for preservation or transplantation.

• Sample Collection and Transportation: Handling and logistics services ensuring safe collection and transport of cord blood samples.

Component Insights:

• Cord Blood: Collection and preservation of blood from the umbilical cord, rich in stem cells.

• Cord Tissue: Preservation of the umbilical cord tissue, which contains stem cells and offers additional therapeutic potential.

Application Insights:

• Cancer Disease: Use of cord blood-derived stem cells for cancer treatment.

• Diabetes: Application of stem cell therapies for diabetes management.

• Blood Disease: Treatment of blood-related disorders using stored cord blood.

• Immune Disorders: Therapies aimed at immune system dysfunction.

• Metabolic Disorders: Use in treatment of metabolic diseases.

• Others: Other therapeutic applications of cord blood stem cells.

Sector Insights:

• Public Cord Blood Banks: Institutions that accept donated cord blood for use by any compatible patient.

• Private Cord Blood Banks: Facilities providing individualized storage solutions for personal or familial use.

Regional Insights:

• North India

• South India

• East India

• West India

REGIONAL INSIGHTS

Not provided in source.

RECENT DEVELOPMENTS & NEWS

In February 2024, STEMCELL Technologies acquired SQZ Biotechnologies' assets, including over 400 patents, enhancing advanced cell therapy delivery methods. This move aims to revolutionize regenerative medicine and cancer treatments, benefiting both global and Indian cord blood banking industries. In September 2023, LifeCell International announced the expansion of its Community Banking Registry to over 75,000 high-quality, consented cord blood units, improving stem cell availability for treating more than 90 life-threatening blood disorders in India.

KEY PLAYERS

• STEMCELL Technologies

• SQZ Biotechnologies

• LifeCell International

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

ABOUT US

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

CONTACT US

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302